Streptococcus pneumoniae type 15b capsular polysaccharide antigen

Identification

Brand Names

Pneumovax 23

Generic Name

Streptococcus pneumoniae type 15b capsular polysaccharide antigen

DrugBank Accession Number

DB10333

Background

Streptococcus pneumoniae type 15b capsular polysaccharide antigen is a vaccine that contains highly purified capsular polysaccharides from the invasive pneumococcal type 15b of Streptococcus pneumoniae. It is an active immunization for intramuscular or subcutaneous injection against pneumococcal disease such as pneumococcal pneumonia and pneumococcal bacteremia.

Type

Biotech

Groups

Approved, Investigational

Biologic Classification

Vaccines
Other vaccines

Synonyms

• pneumococcal capsular polysaccharide type 15B vaccine

Poor quality drug data slowing you down?

Unlock 38% more drug discovery time and eliminate decision-making doubts with this one-stop guide to quality drug data.

Download eBook

Poor quality drug data slowing you down?

Download eBook

Pharmacology

Indication

Not Available

Reduce drug development failure rates

Build, train, & validate machine-learning models
with evidence-based and structured datasets.

See how

Build, train, & validate predictive machine-learning models with structured datasets.

See how

Associated Conditions

Indication Type	Indication	Combined Product Details	Approval Level	Age Group	Patient Characteristics	Dose Form
Used in combination to prevent	Pneumococcal infection		••••••••••••			•••••••••• ••••••••• ••••••••
Used in combination to prevent	Active pneumococcal infection	Combination Product in combination with: Streptococcus pneumoniae type 2 capsular polysaccharide antigen (DB10320)	••••••••••••

Create Account

Contraindications & Blackbox Warnings

Prevent Adverse Drug Events Today

Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.

Learn more

Avoid life-threatening adverse drug events with our Clinical API

Learn more

Pharmacodynamics

Not Available

Mechanism of action

Not Available

Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism

Not Available

Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects

Improve decision support & research outcomes

With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!

See the data

Improve decision support & research outcomes with our structured adverse effects data.

See a data sample

Toxicity

Not Available

Pathways

Not Available

Pharmacogenomic Effects/ADRs Browse all" title="About SNP Mediated Effects/ADRs" id="snp-actions-info" class="drug-info-popup" href="javascript:void(0);">

Not Available

Interactions

Drug Interactions Learn More" title="About Drug Interactions" id="structured-interactions-info" class="drug-info-popup" href="javascript:void(0);">

This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.

Not Available

Food Interactions

Not Available

Products

Drug product information from 10+ global regions

Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.

Access now

Access drug product information from over 10 global regions.

Access now

Mixture Products

Name	Ingredients	Dosage	Route	Labeller	Marketing Start	Marketing End	Region	Image
Apexxnar	Streptococcus pneumoniae type 15b capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 1 capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 10a capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 11a capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 12f capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 14 capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 18c capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 19a capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 19f capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 22F capsular polysaccharide diphtheria CRM197 protein conjugate antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 23f capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 3 capsular polysaccharide diphtheria CRM197 protein conjugate antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 33F capsular polysaccharide diphtheria CRM197 protein conjugate antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 4 capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 5 capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 6a capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 6b capsular polysaccharide antigen (4.4 µg/0.5ml) + Streptococcus pneumoniae type 7f capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 8 capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 9v capsular polysaccharide antigen (2.2 µg/0.5ml)	Injection, suspension	Intramuscular	Pfizer Europe Ma Eeig	2022-06-06	Not applicable
Apexxnar	Streptococcus pneumoniae type 15b capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 1 capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 10a capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 11a capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 12f capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 14 capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 18c capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 19a capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 19f capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 22F capsular polysaccharide diphtheria CRM197 protein conjugate antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 23f capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 3 capsular polysaccharide diphtheria CRM197 protein conjugate antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 33F capsular polysaccharide diphtheria CRM197 protein conjugate antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 4 capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 5 capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 6a capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 6b capsular polysaccharide antigen (4.4 µg/0.5ml) + Streptococcus pneumoniae type 7f capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 8 capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 9v capsular polysaccharide antigen (2.2 µg/0.5ml)	Injection, suspension	Intramuscular	Pfizer Europe Ma Eeig	2022-06-06	Not applicable
Apexxnar	Streptococcus pneumoniae type 15b capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 1 capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 10a capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 11a capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 12f capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 14 capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 18c capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 19a capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 19f capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 22F capsular polysaccharide diphtheria CRM197 protein conjugate antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 23f capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 3 capsular polysaccharide diphtheria CRM197 protein conjugate antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 33F capsular polysaccharide diphtheria CRM197 protein conjugate antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 4 capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 5 capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 6a capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 6b capsular polysaccharide antigen (4.4 µg/0.5ml) + Streptococcus pneumoniae type 7f capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 8 capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 9v capsular polysaccharide antigen (2.2 µg/0.5ml)	Injection, suspension	Intramuscular	Pfizer Europe Ma Eeig	2022-06-06	Not applicable
Apexxnar	Streptococcus pneumoniae type 15b capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 1 capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 10a capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 11a capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 12f capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 14 capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 18c capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 19a capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 19f capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 22F capsular polysaccharide diphtheria CRM197 protein conjugate antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 23f capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 3 capsular polysaccharide diphtheria CRM197 protein conjugate antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 33F capsular polysaccharide diphtheria CRM197 protein conjugate antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 4 capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 5 capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 6a capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 6b capsular polysaccharide antigen (4.4 µg/0.5ml) + Streptococcus pneumoniae type 7f capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 8 capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 9v capsular polysaccharide antigen (2.2 µg/0.5ml)	Injection, suspension	Intramuscular	Pfizer Europe Ma Eeig	2022-06-06	Not applicable
Apexxnar	Streptococcus pneumoniae type 15b capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 1 capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 10a capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 11a capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 12f capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 14 capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 18c capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 19a capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 19f capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 22F capsular polysaccharide diphtheria CRM197 protein conjugate antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 23f capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 3 capsular polysaccharide diphtheria CRM197 protein conjugate antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 33F capsular polysaccharide diphtheria CRM197 protein conjugate antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 4 capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 5 capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 6a capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 6b capsular polysaccharide antigen (4.4 µg/0.5ml) + Streptococcus pneumoniae type 7f capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 8 capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 9v capsular polysaccharide antigen (2.2 µg/0.5ml)	Injection, suspension	Intramuscular	Pfizer Europe Ma Eeig	2022-06-06	Not applicable

Categories

Drug Categories

• Actively Acquired Immunity
• Inactivated Pneumococcal Vaccine

Classification

Not classified

Affected organisms

Not Available

Chemical Identifiers

UNII

667Y1EG6EW

CAS number

Not Available

References

General References

Not Available

External Links

PubChem Substance

347910512

RxNav

854940

Clinical Trials

Clinical Trials Learn More" title="About Clinical Trials" id="clinical-trials-info" class="drug-info-popup" href="javascript:void(0);">

Phase	Status	Purpose	Conditions	Count
4	Completed	Basic Science	Aging / Pneumonia	1
4	Completed	Diagnostic	Crohn's Disease (CD)	1
4	Completed	Prevention	Acute Lymphoblastic Leukaemias (ALL)	1
4	Completed	Prevention	Asthma	2
4	Completed	Prevention	Bone Marrow Transplant (BMT)	1

Pharmacoeconomics

Manufacturers

Not Available

Packagers

Not Available

Dosage Forms

Form	Route	Strength
Injection, suspension	Intramuscular
Injection, solution	Intramuscular; Subcutaneous
Solution	Intramuscular; Subcutaneous
Injection, solution	Subcutaneous
Injection

Prices

Not Available

Patents

Not Available

Properties

State

Not Available

Experimental Properties

Not Available

×

Identify potential medication risks

Easily compare up to 40 drugs with our drug interaction checker.

Get severity rating, description, and management advice.

Learn more

Drug created at December 01, 2015 20:03 / Updated at June 12, 2020 16:53